No. Pillcheck’s test does not report on biologics, such as monoclonal antibodies, insulin, or other protein-based therapies. This is because:
- Biologics are broken down by the body’s normal protein degradation pathways, not by the liver’s drug-metabolizing enzymes (like CYP2D6 or CYP2C19) that pharmacogenetic testing evaluates.
- There are currently no pharmacogenetic variants with sufficient clinical evidence (per CPIC or DPWG guidelines) to predict how a person will respond to a given biologic.
As pharmacogenomic research evolves, this may change, and Pillcheck will update its test to reflect new clinically validated evidence.
Was this article helpful?
That’s Great!
Thank you for your feedback
Sorry! We couldn't be helpful
Thank you for your feedback
Feedback sent
We appreciate your effort and will try to fix the article